Author Question: What sweeping change to diagnosis (that was introduced in DSM-III) was eliminated in DSM-5? a) ... (Read 47 times)

olgavictoria

  • Hero Member
  • *****
  • Posts: 528
What sweeping change to diagnosis (that was introduced in DSM-III) was eliminated in DSM-5?
 
  a) Having the clinical conditions on Axis I
  b) Having a multiaxial system
  c) Having diagnoses for sexual dysfunctions
  d) Having to consider medical conditions

Question 2

The 19th century efforts at developing a classification scheme for mental illness was
 
  a) never ratified.
  b) based largely upon the ideas of Emil Kraeplin, as they are today.
  c) driven by empirical observations.
  d) all of the above are correct.



carlsona147

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

Thanks for the answer, I sent you a PM for another one.

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library